ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
132.56
-0.70 (-0.53%)
At close: Jul 1, 2026, 4:00 PM EDT
138.17
+5.61 (4.23%)
Pre-market: Jul 2, 2026, 6:32 AM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 80 employees as of March 31, 2026. The number of employees increased by 11 or 15.94% since the number was last reported on December 31, 2025.
Employees
80
Change
11
Growth
15.94%
Revenue / Employee
$70,910
Profits / Employee
-$4,787,847
Market Cap
10.67B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 80 | 11 | 15.94% | 80 | 0 |
| Dec 31, 2025 | 69 | 0 | - | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Madrigal Pharmaceuticals | 915 |
| Corcept Therapeutics | 730 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Krystal Biotech | 295 |
ABVX News
- 1 hour ago - Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet - WSJ
- 4 hours ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) - GlobeNewsWire
- 11 hours ago - Abivax nears $11 billion valuation after fundraising eases M&A pressure - Reuters
- 21 hours ago - Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares - GlobeNewsWire
- 21 hours ago - Abivax announces trading resumption of its ordinary shares on Euronext Paris - GlobeNewsWire
- 22 hours ago - Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares - GlobeNewsWire
- 1 day ago - Abivax announces temporary trading halt of its ordinary shares on Euronext Paris - GlobeNewsWire
- 1 day ago - Abivax Announces Launch of Public Offering of American Depositary Shares - GlobeNewsWire